BRAF and intrahepatic cholangiocarcinoma: BRAF variants were not associated with survival or recurrence in the ICC cohort in this study, which is not consistent with some previous findings in cancers such as melanoma and CRC.26,27 We found that this inconsistency was mainly caused by the lower proportion of BRAF V600E variants in the ICC cohort compared with that in melanoma and CRC cohorts.